Showing results (71-80 of 142) with videos related to

Sort By:
Pageof 15
Leukemia & Lymphoma|December 30, 2020
The propriety of upgrading responses to venetoclax + azacitidine in newly diagnosed patients with acute myeloid leukemiaDiana Abbott, Evan Cherry, Maria Amaya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 11, 2013
A multicenter, first-in-pediatrics, phase 1, pharmacokinetic and pharmacodynamic study of ridaforolimus in patients with refractory solid tumorsLia Gore, Tanya M Trippett, Howard M Katzenstein, et al.
Anti-Cancer Drugs|November 29, 2007
A phase I safety, tolerability, and pharmacokinetic study of enzastaurin combined with capecitabine in patients with advanced solid tumorsD Ross Camidge, S Gail Eckhardt, Lia Gore, et al.
Pediatric Blood & Cancer|October 2, 2012
A multi-center phase Ib study of oxaliplatin (NSC#266046) in combination with fluorouracil and leucovorin in pediatric patients with advanced solid tumorsMargaret E Macy, Tracey Duncan, James Whitlock, et al.
Pediatric Blood & Cancer|August 8, 2023
Palbociclib in combination with chemotherapy in pediatric and young adult patients with relapsed/refractory acute lymphoblastic leukemia and lymphoma: A Children's Oncology Group study (AINV18P1)Elizabeth A Raetz, David T Teachey, Charles Minard, et al.
Cancer Chemotherapy and Pharmacology|March 6, 2008
A phase I pharmacological and biological study of PI-88 and docetaxel in patients with advanced malignanciesLaura Q M Chow, Daniel L Gustafson, Cindy L O'Bryant, et al.
Pediatric Blood & Cancer|April 15, 2017
A phase 1 study of the CXCR4 antagonist plerixafor in combination with high-dose cytarabine and etoposide in children with relapsed or refractory acute leukemias or myelodysplastic syndrome: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study (POE 10-03)Todd M Cooper, Edward Allan Racela Sison, Sharyn D Baker, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2022
Targeted inhibitors and antibody immunotherapies: Novel therapies for paediatric leukaemia and lymphomaErica Brivio, André Baruchel, Auke Beishuizen, et al.
Neuro-Oncology|May 22, 2014
Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine gliomaUte Bartels, Johannes Wolff, Lia Gore, et al.
Blood|May 17, 2013
Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapyDavid T Teachey, Susan R Rheingold, Shannon L Maude, et al.
Pageof 15